Poseida Therapeutics (PSTX) - P/B ratio
P/B ratio as of January 2025 : 10.6
According to Poseida Therapeutics's latest financial reports the company has a price-to-book ratio of 6.13778.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
P/B ratio by year
Year |
P/B ratio |
Change |
2024-12-31 | 10.5 | 239.79% |
2023-12-31 | 3.10 | 27.59% |
2022-12-31 | 2.43 | -10.91% |
2021-12-31 | 2.73 | 5.22% |
2020-12-31 | 2.59 | |
2019-12-31 | N/A | |
P/B ratio for similar companies or competitors
Company | P/B ratio | P/B ratio differencediff. | Country |
| 2.09 | -80.34% | ๐บ๐ธ USA |